23 September 2021

Aquis Exchange PLC

("Aquis" or the "Company")

 Exercise of Share Options, Director Dealing and Total Voting Rights

Aquis Exchange PLC (AIM: AQX), the exchange services group, announces that on 22 September 2021 it received notification that certain employees have exercised options under the Company's EMI Option Scheme over 9,294 ordinary shares of 10p each in the Company ("Ordinary Shares") at an exercise price of £2.69 per share.

In addition, Jonathan Clelland, CFO and COO of the Company, on 23 September 2021 sold 100,000 Ordinary Shares at a price of £7.20 following the exercise of options under the Company's EMI Option Scheme in June of this year. Following this, Jonathan Clelland now holds 547,401 Ordinary Shares in the Company, representing 2.0% of the Company's issued share capital.

Application has been made for 9,294 new Ordinary Shares to be admitted to trading on AIM, which is expected to take place on 1 October 2021. The new Ordinary Shares will rank pari pasu with the existing Ordinary Shares in issue.

Total Voting Rights

In accordance with the provisions of the Disclosure Guidance and Transparency Rules of the FCA, the Company confirms that, following this issue, its issued share capital will comprise 27,502,257 Ordinary Shares. All Ordinary Shares shall have equal voting rights and none of the Ordinary Shares are held in treasury. Accordingly, the figure of 27,502,257 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.

Enquiries:

Notes to Editors

About Aquis Exchange

Aquis Exchange PLC is an exchange services group, which operates pan-European cash equities trading businesses (Aquis Exchange), growth and regulated primary markets (Aquis Stock Exchange/AQSE) and develops/licenses exchange software to third parties (Aquis Technologies).

Aquis Exchange is authorised and regulated by the UK Financial Conduct Authority and France's Autorité des Marchés Financiers to operate Multilateral Trading Facility businesses in the UK and in EU27 respectively. Aquis operates a lit order book and does not allow aggressive non-client proprietary trading, which has resulted in lower toxicity and signalling risk on Aquis than other trading venues in Europe. According to independent studies, trades on Aquis are less likely to lead to price movement than on other lit markets. Aquis uses a subscription pricing model which works by charging users according to the message traffic they generate, rather than a percentage of the value of each stock that they trade.

Aquis Stock Exchange (AQSE) is a stock market providing primary and secondary markets for equity and debt products. It is authorised as a Recognised Investment Exchange, which allows it to operate a regulated listings venue. AQSE, which used to be known as NEX Exchange Ltd., was acquired by Aquis in March 2020 from CME Inc. The AQSE Growth Market is divided into two segments 'Access' and 'Apex', with different levels of admission criteria. The Access market focuses on earlier stage growth companies, while Apex is the intended market for larger, more established businesses.

Aquis Technologies is the software and technology division of Aquis Exchange PLC. It creates and licenses cutting-edge, cost-effective matching engine and trade surveillance technology for banks, brokers, investment firms and exchanges.

Aquis Exchange PLC (AQX.L) is listed on the Alternative Investment Market of the LSE (AIM) market. For more information, please go to www.aquis.eu